Looking At Merck & Co's Recent Unusual Options Activity

Investors with a lot of money to spend have taken a bullish stance on Merck & Co MRK.

And retail traders should know.

We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.

Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with MRK, it often means somebody knows something is about to happen.

So how do we know what these investors just did?

Today, Benzinga's options scanner spotted 9 uncommon options trades for Merck & Co.

This isn't normal.

The overall sentiment of these big-money traders is split between 55% bullish and 44%, bearish.

Out of all of the special options we uncovered, 5 are puts, for a total amount of $217,895, and 4 are calls, for a total amount of $328,417.

What's The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $105.0 to $125.0 for Merck & Co over the last 3 months.

Volume & Open Interest Trends

Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Merck & Co's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Merck & Co's substantial trades, within a strike price spectrum from $105.0 to $125.0 over the preceding 30 days.

Merck & Co Call and Put Volume: 30-Day Overview

Biggest Options Spotted:

About Merck & Co

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

In light of the recent options history for Merck & Co, it's now appropriate to focus on the company itself. We aim to explore its current performance.

Merck & Co's Current Market Status

• Trading volume stands at 3,503,663, with MRK's price down by -0.97%, positioned at $121.01.
• RSI indicators show the stock to be may be approaching oversold.
• Earnings announcement expected in 36 days.

Expert Opinions on Merck & Co

In the last month, 3 experts released ratings on this stock with an average target price of $124.66666666666667.

• Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $135.
• Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $135.
• In a cautious move, an analyst from Societe Generale downgraded its rating to Sell, setting a price target of $104.

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Merck & Co with Benzinga Pro for real-time alerts.